HEALthy Beginnings for Homelessness
(HB Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment HEALthy Beginnings for Homelessness?
Research shows that case management and supportive housing interventions are effective for improving health outcomes in homeless individuals, including better mental health and reduced substance misuse. Additionally, comprehensive services can help chronically homeless adults maintain housing and improve their quality of life.12345
How is the HEALthy Beginnings treatment for homelessness different from other treatments?
What is the purpose of this trial?
This is a mixed methods pilot feasibility trial of HEALthy Beginnings, an innovative, nurse-driven intervention. Middle-aged and older, homeless women (MAO-HW) will participate in the HEALthy Beginnings intervention and select MAO-HW will be invited to participate in post-intervention qualitative focus groups to evaluate the program.
Research Team
Benissa E. Salem, PhD, MSN, RN, CNL, PHN
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for middle-aged and older women who are homeless. It aims to help them manage chronic diseases and promote overall health. Participants should be interested in joining a nurse-led program that includes group activities.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in the HEALthy Beginnings intervention, including nine group sessions and six private sessions
Post-intervention Evaluation
Participants complete a follow-up questionnaire and participate in a qualitative focus group to evaluate the intervention
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- HEALthy Beginnings
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Hillman Foundation
Collaborator